On behalf of the Board, Maybank Investment Bank Berhad ("Maybank IB") wishes to announce that the Company has, on 18 September 2026, entered into a conditional share sale and purchase agreement with Batu Kawan Berhad ("BKB") and Enternal Edge Sdn Bhd ("EESB") (collectively, "Vendors") for the proposed acquisition of 100% equity interest in Chemical Company of Malaysia Berhad ("CCM") from BKB and EESB for a total purchase consideration of RM939.9 million to be satisfied via a combination of cash of approximately RM438.5 million and the allotment and issuance of 262,500,000 new ordinary shares in TMK ("TMK Shares") ("Consideration Share(s)") at an issue price of RM1.9098 per Consideration Share ("Proposed Acquisition").

In conjunction with the Proposed Acquisition, BKB, being one of the Vendors will be seeking the approval of the Securities Commission Malaysia for the proposed exemption for BKB and persons acting in concert with it ("PACs") from the obligation to undertake a mandatory take-over offer for all the remaining TMK Shares not already owned by BKB and the PACs upon completion of the Proposed Acquisition.

Further details on the Proposals are set out in the attachment below.

This announcement is dated 18 September 2026.